loading
Aprea Therapeutics Inc stock is traded at $1.71, with a volume of 1,824. It is up +1.18% in the last 24 hours and down -1.16% over the past month. Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company. The group is focused on precision oncology through synthetic lethality. Its pipeline products include ATRN-119, a clinical-stage small molecule ATR inhibitor in development for solid tumor indications. APR-1051, an oral, small-molecule WEE1 inhibitor, recently entered the clinic.
See More
Previous Close:
$1.69
Open:
$1.69
24h Volume:
1,824
Relative Volume:
0.04
Market Cap:
$9.57M
Revenue:
-
Net Income/Loss:
$-14.29M
P/E Ratio:
-0.4286
EPS:
-3.99
Net Cash Flow:
$-12.27M
1W Performance:
-4.47%
1M Performance:
-1.16%
6M Performance:
-50.15%
1Y Performance:
-46.89%
1-Day Range:
Value
$1.69
$1.73
1-Week Range:
Value
$1.55
$1.82
52-Week Range:
Value
$1.412
$5.01

Aprea Therapeutics Inc Stock (APRE) Company Profile

Name
Name
Aprea Therapeutics Inc
Name
Phone
215-948-4119
Name
Address
3805 OLD EASTON ROAD, DOYLESTOWN, MA
Name
Employee
8
Name
Twitter
Name
Next Earnings Date
2024-12-07
Name
Latest SEC Filings
Name
APRE's Discussions on Twitter

Compare APRE with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
APRE
Aprea Therapeutics Inc
1.73 9.40M 0 -14.29M -12.27M -3.99
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
383.40 93.98B 11.42B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
562.53 59.67B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
435.38 57.53B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
ARGX
Argen X Se Adr
645.91 40.50B 3.05B 1.28B -614.78M 19.58
Biotechnology icon
ONC
Beone Medicines Ltd Adr
287.45 34.26B 3.81B -644.79M -669.77M -6.24

Aprea Therapeutics Inc Stock (APRE) Upgrades & Downgrades

Date Action Analyst Rating Change
Dec-28-20 Downgrade Robert W. Baird Outperform → Neutral
Dec-16-20 Initiated Berenberg Buy
Sep-29-20 Resumed JP Morgan Neutral
Jun-22-20 Initiated H.C. Wainwright Neutral
Apr-21-20 Initiated Robert W. Baird Outperform
Oct-28-19 Initiated JP Morgan Neutral
Oct-28-19 Initiated Morgan Stanley Equal-Weight
Oct-28-19 Initiated RBC Capital Mkts Outperform
View All

Aprea Therapeutics Inc Stock (APRE) Latest News

pulisher
08:13 AM

Aprea Therapeutics, Inc. SEC 10-Q Report - TradingView

08:13 AM
pulisher
08:06 AM

Aprea Therapeutics Reports Second Quarter 2025 Financial Results and Provides a Clinical Update - The Manila Times

08:06 AM
pulisher
06:42 AM

Analyzing drawdowns of Aprea Therapeutics Inc. with statistical toolsFree Market Momentum and Signal Alerts - Newser

06:42 AM
pulisher
03:44 AM

Aprea Therapeutics Inc. stock retracement – recovery analysisStock Market Watch with Smart Filters - Newser

03:44 AM
pulisher
03:30 AM

How hedge fund analytics apply to Aprea Therapeutics Inc. stockTechnical Trade Plan with Entry Checklist - Newser

03:30 AM
pulisher
02:20 AM

How to forecast Aprea Therapeutics Inc. trends using time seriesBreakout Screener With Alert Based Timing - Newser

02:20 AM
pulisher
01:29 AM

Why Aprea Therapeutics Inc. stock attracts strong analyst attentionInsider Strategy for High Conviction Picks - Newser

01:29 AM
pulisher
12:58 PM

Published on: 2025-08-11 23:58:33 - Newser

12:58 PM
pulisher
12:35 PM

How Aprea Therapeutics Inc. stock performs during market volatilityNeural Network Based Equity Prediction System - Newser

12:35 PM
pulisher
Aug 11, 2025

How to interpret RSI for Aprea Therapeutics Inc. stockFree Daily Stock Market Swing Alerts - Newser

Aug 11, 2025
pulisher
Aug 11, 2025

What’s next for Aprea Therapeutics Inc. stock priceChart Scanner for Swing Trade Timing - Newser

Aug 11, 2025
pulisher
Aug 11, 2025

Long term hold vs stop loss in Aprea Therapeutics Inc.Free Weekly Return Pick Forecast Reports - Newser

Aug 11, 2025
pulisher
Aug 11, 2025

Is Aprea Therapeutics Inc. meeting your algorithmic filter criteriaMarket Opportunity Tracker for Swing Traders - Newser

Aug 11, 2025
pulisher
Aug 11, 2025

Signal strength of Aprea Therapeutics Inc. stock in tech scannersExit Strategy Guide With Risk Control Plan - Newser

Aug 11, 2025
pulisher
Aug 10, 2025

Is Aprea Therapeutics Inc. forming a bottoming baseTechnical Trend Forecast for Investors - Newser

Aug 10, 2025
pulisher
Aug 10, 2025

Can you recover from losses in Aprea Therapeutics Inc.Rapid Trade Forecast Based on Indicators - Newser

Aug 10, 2025
pulisher
Aug 10, 2025

Is Aprea Therapeutics Inc. Stock Overbought or Oversold RSI Indicator AnalysisFree Real Time Trade Opportunity Alerts - Newser

Aug 10, 2025
pulisher
Aug 10, 2025

Buy Signal for Aprea Therapeutics Inc. Stock Key Technical Indicators to WatchMomentum Screener with Buy and Sell Areas - Newser

Aug 10, 2025
pulisher
Aug 10, 2025

Is it too late to sell Aprea Therapeutics Inc.Daily Pattern Analysis with Return Forecast - Newser

Aug 10, 2025
pulisher
Aug 09, 2025

Combining price and volume data for Aprea Therapeutics Inc.Predictable Income Summary for Long-Term Trades - Newser

Aug 09, 2025
pulisher
Aug 09, 2025

Multi asset correlation models including Aprea Therapeutics Inc.Entry Confirmation Based on Volatility Analysis - Newser

Aug 09, 2025
pulisher
Aug 09, 2025

What candlestick patterns are forming on Aprea Therapeutics Inc.Free Early Entry Tips With Low Risk Zone - Newser

Aug 09, 2025
pulisher
Aug 09, 2025

Aprea Therapeutics (APRE) to Release Quarterly Earnings on Monday - Defense World

Aug 09, 2025
pulisher
Aug 08, 2025

Strategies to average down on Aprea Therapeutics Inc.Swing Reversal Forecast Based on Patterns - Newser

Aug 08, 2025
pulisher
Aug 08, 2025

Aprea Therapeutics APRE 2025Q2 Earnings Preview Upside Potential Amid Breakthrough Therapy Designation - AInvest

Aug 08, 2025
pulisher
Aug 08, 2025

Key resistance and support levels for Aprea Therapeutics Inc.Buy Opportunity Forecast for Fast Traders - Newser

Aug 08, 2025
pulisher
Aug 08, 2025

Applying Wyckoff theory to Aprea Therapeutics Inc. stockTrading Opportunities Forecast by AI Insight - Newser

Aug 08, 2025
pulisher
Aug 07, 2025

Trend analysis for Aprea Therapeutics Inc. this week3-Day Market Movement Forecast Analysis - Newser

Aug 07, 2025
pulisher
Aug 05, 2025

Quantitative breakdown of Aprea Therapeutics Inc. recent moveAutomated AI Forecast with Trading Alerts - Newser

Aug 05, 2025
pulisher
Aug 05, 2025

Real time social sentiment graph for Aprea Therapeutics Inc.Risk Aware Swing Trade Analysis Insights - Newser

Aug 05, 2025
pulisher
Aug 05, 2025

Key metrics from Aprea Therapeutics Inc.’s quarterly dataWeekly Chart Watchlist with Trade Guidance - Newser

Aug 05, 2025

Aprea Therapeutics Inc Stock (APRE) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$36.48
price up icon 0.80%
$80.95
price up icon 2.25%
$27.05
price down icon 3.01%
$113.74
price up icon 0.78%
$110.00
price up icon 0.68%
biotechnology ONC
$287.25
price down icon 1.05%
Cap:     |  Volume (24h):